- Report
- November 2022
- 82 Pages
Middle East, Africa
From €1373EUR$1,500USD£1,167GBP
- Report
- November 2022
- 82 Pages
Europe
From €1373EUR$1,500USD£1,167GBP
- Report
- December 2023
- 250 Pages
Global
€4572EUR$4,995USD£3,886GBP
- Report
- November 2024
- 84 Pages
Global
From €3500EUR$4,096USD£3,079GBP
- Report
- January 2024
- 94 Pages
Global
From €3500EUR$4,096USD£3,079GBP
- Report
- October 2023
- 114 Pages
Global
From €3500EUR$4,096USD£3,079GBP
- Report
- October 2023
- 140 Pages
Global
From €3500EUR$4,096USD£3,079GBP
- Report
- May 2025
- 50 Pages
Global
From €2426EUR$2,650USD£2,062GBP
- Report
- May 2025
- 50 Pages
Global
From €2426EUR$2,650USD£2,062GBP
- Report
- October 2024
- 240 Pages
Global
From €1701EUR$1,859USD£1,446GBP
€2430EUR$2,655USD£2,066GBP
- Report
- April 2022
- 210 Pages
Global
From €2215EUR$2,419USD£1,882GBP
€3164EUR$3,456USD£2,689GBP

Clotrimazole is an antifungal drug used to treat a variety of infectious diseases caused by fungi. It is commonly used to treat skin infections such as athlete's foot, jock itch, and ringworm, as well as vaginal yeast infections. It is also used to treat fungal infections of the mouth, throat, and lungs. Clotrimazole works by inhibiting the growth of fungi, preventing them from spreading and causing infection.
The clotrimazole market is a rapidly growing segment of the infectious diseases drugs market. It is widely used in both the developed and developing world, and is available in both prescription and over-the-counter forms. The drug is well-tolerated and has a low risk of side effects, making it an attractive option for treating fungal infections.
Some of the major companies in the clotrimazole market include GlaxoSmithKline, Pfizer, Merck, Novartis, and Bayer. These companies produce a variety of clotrimazole-based products, ranging from creams and ointments to tablets and capsules. Show Less Read more